Kiniksa Pharmaceuticals International, plc SEC filings KNSA

Kiniksa Pharmaceuticals International, plc has 776 filings in SEC EDGAR's recent list, going back to Feb 27, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
10-K Annual report Feb 24, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 21, 2025 Dec 31, 2024
10-K Annual report Feb 25, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 23, 2024 Dec 31, 2023
10-K Annual report Feb 28, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
10-K Annual report Mar 2, 2023 Dec 31, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K Annual report Mar 5, 2020 Dec 31, 2019
10-K Annual report Mar 12, 2019 Dec 31, 2018

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KNSA (Nasdaq)
Fiscal year ends
December 31
Headquarters
London
SEC filer status
Large accelerated filer
SEC CIK
1730430
Former names
Kiniksa Pharmaceuticals, Ltd. (until Jun 28, 2024)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.